Earnings Preview For Mersana Therapeutics

Mersana Therapeutics (NASDAQ:MRSN) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Mersana Therapeutics will report an earnings per share (EPS) of $-0.17.

The market awaits Mersana Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Performance in Previous Earnings

Last quarter the company missed EPS by $0.03, which was followed by a 8.89% drop in the share price the next day.

Here's a look at Mersana Therapeutics's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

-0.17

-0.18

-0.16

-0.36

EPS Actual

-0.20

-0.16

-0.16

-0.35

Price Change %

-9.0%

10.0%

12.0%

-3.0%

Performance of Mersana Therapeutics Shares

Shares of Mersana Therapeutics were trading at $2.53 as of November 11. Over the last 52-week period, shares are up 64.29%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analysts' Take on Mersana Therapeutics

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Mersana Therapeutics.

Analysts have given Mersana Therapeutics a total of 2 ratings, with the consensus rating being Buy. The average one-year price target is $4.0, ...